A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients
Phase 2
Recruiting
- Conditions
- Vaginitis
- Interventions
- Drug: WXSH0102/placeboDrug: fluconazole capsules/placebo
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Cisen Pharmaceutical CO., LTD.
- Target Recruit Count
- 108
- Registration Number
- NCT06771063
- Locations
- 🇨🇳
251 Yaojiayuan Road, Chaoyang District, Beijing, Beijing, Beijing, China
🇨🇳Beijing Obstetrics and Gynecology Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath